Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).

被引：0
|
作者：
Spanu, A
Schillaci, O
Falchi, A
Marongiu, P
Pisu, N
Madeddu, G
Solinas, ME
Solinas, P
Scopinaro, F
Madeddu, G
机构：
[1] Univ Sassari, I-07100 Sassari, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Roma La Sapienza, Rome, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1206
引用
收藏
页码：299P / 299P
页数：1
相关论文
共 50 条
  • [1] Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors
    Schillaci, O
    Spanu, A
    Scopinaro, F
    Falchi, A
    Danieli, R
    Marongiu, P
    Pisu, N
    Madeddu, G
    Delle Fave, G
    Madeddu, G
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (03) : 359 - 368
  • [2] The role of F-18-FDG-PET in gastroenteropancreatic (GEP) neuroendocrine tumors compared to somatostatin receptor scintigraphy (SRS).
    Lang, O
    Bihl, H
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 125P - 125P
  • [3] Liver metastases in gastroenteropancreatic neuroendocrine tumours - treatment methods
    Gut, Pawel
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (03): : 207 - 214
  • [4] Liver Metastases from Neuroendocrine Tumours of the Gastroenteropancreatic System - Therapeutic Strategies
    Auernhammer, C. J.
    Jauch, K. W.
    Hoffmann, J. N.
    ZENTRALBLATT FUR CHIRURGIE, 2009, 134 (05): : 410 - 417
  • [5] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH IN-111 PENTATREOTIDE IN GASTROENTEROPANCREATIC ENDOCRINE TUMORS (GEP)
    IVANCEVIC, V
    NAUCK, C
    SANDROCK, D
    KOGLER, A
    MUNZ, DL
    CREUTZFELDT, W
    EMRICH, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 736 - 736
  • [6] Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours
    de Herder, WW
    Hofland, LJ
    van der Lely, AJ
    Lamberts, SWJ
    ENDOCRINE-RELATED CANCER, 2003, 10 (04) : 451 - 458
  • [7] Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
    Lebtahi, R
    Cadiot, G
    Delahaye, N
    Genin, R
    Daou, D
    Peker, MC
    Chosidow, D
    Faraggi, M
    Mignon, M
    Le Guludec, D
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1602 - 1608
  • [8] Specificity increase of somatostatin receptor imaging (SRI) in gastroenteropancreatic neuroendocrine tumors (GEP).
    Chiti, A
    Briganti, V
    Fanti, S
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 285P - 285P
  • [9] Autoradiographic in vivo distribution of 111In-pentetreotide in neuroendocrine gastroenteropancreatic (GEP) tumours and comparison with scintigraphy
    Petegnief, Y
    Lebtahi, R
    Vissuzaine, C
    Marmuse, JP
    Sobhani, I
    Mignon, M
    Le guludec, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1176 - 1176
  • [10] MORPHOLOGICAL IMAGING AND SOMATOSTATIN RECEPTOR SCINTIGRAPHY OF GASTROENTEROPANCREATIC (GEP) TUMORS - A COMPARATIVE-STUDY
    JAMAR, F
    LENERS, N
    FIASSE, R
    PAUWELS, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 737 - 737
12345